Concerns over leaks compelled the top U.S. infectious disease official to reveal data on Gilead Sciences Inc’s experimental drug remdesivir, the first in a scientifically rigorous clincial trial to show benefit in treating COVID-19.
from Reuters: Health News https://ift.tt/2zDRvpL
No comments:
Post a Comment